Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 55%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT is well positioned because its triple-net healthcare lease model produces durable, contractually driven revenue while shifting property-level costs to tenants, supporting stable cash generation and margin visibility. The company has also shown strong capital deployment discipline, completing $1.4 billion of deals YTD and $710 million of new investments in 3Q26, with estimates that these transactions add $0.08/share to FFO and AFFO and lift 2026 FFO to $2.07/share. Confidence is further supported by a $540 million pipeline, improved SNF fundamentals, and stabilizing tenant-credit concerns around ENSG and PACS, which together could enhance valuation and sustain incremental growth.

Bears say

CareTrust REIT is viewed cautiously because its earnings growth is heavily dependent on external SNF, SHOP, and UK care home acquisitions rather than organic growth, leaving results exposed to a more competitive transaction market and compressed cap rates. The outlook is also pressured by regulatory and reimbursement uncertainty, especially the risk of Medicaid cuts, which could weaken operator coverage, stall earnings growth at its 2026 run-rate, and reduce valuation support. Additional concerns include PACS-related headline risk, an unfinished DOJ investigation, and the company’s sensitivity to labor, capital costs, and unpredictable healthcare regulation.

CareTrust REIT (CTRE) has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 55% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 11 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Oct 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $42.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $42.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.